Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism
JACC: Cardiovascular Interventions · 2023-11 · 16 (21) · 2644-2651
DOI: 10.1016/j.jcin.2023.07.042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2023-11. Verfasst von Robert S Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism, Thrombolytic Therapy. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The optimal treatment strategy of patients with pulmonary embolism (PE) (especially those with intermediate risk) continues to evolve and remains controversial. OBJECTIVES: This study sought to compare the efficacy and safety of anticoagulation (AC) alone, catheter-directed thrombolysis (CDT), and systemic thrombolysis (ST) in patients with acute PE. METHODS: PubMed and EMBASE were searched for randomized controlled trials or observational studies which compared outcomes of AC alone, CDT, and ST in acute PE. Efficacy outcome was all-cause mortality. Safety outcomes were major bleeding and intracranial hemorrhage (ICH). RESULTS: We identified 45 studies (17 randomized controlled trials, 2 prospective nonrandomized trials, and 26 retrospective observational trials), which included 81,705 patients. When compared with AC alone, CDT had lower mortality (OR: 0.55; 95% CI: 0.39-0.80) but higher major bleeding (OR: 1.84; 95% CI: 1.10-3.08) and numerically higher ICH (OR: 1.51; 95% CI: 0.75-3.04). ST was associated with no difference in mortality but higher major bleeding (OR: 2.16; 95% CI: 1.38-3.38) and ICH (OR: 2.26; 95% CI: 1.14-4.48) when compared with AC alone. The risk of mortality (OR: 2.05; 95% CI: 1.46-2.89) and ICH (OR: 1.50; 95% CI: 1.13-1.99) was higher with ST when compared with CDT. Findings were similar when analysis was restricted to trials of intermediate risk PE. CONCLUSIONS: In patients with acute PE, when compared with AC alone, CDT was associated with a lower mortality but higher risk of bleeding. Moreover, CDT had an enhanced safety profile when compared with ST.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA.
- Department of Cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA.
- University Hospital of Wales, Cardiff University, Cardiff, United Kingdom.
- Division of Pulmonary, Critical Care, and Sleep Medicine, Bellevue Hospital, NYU Grossman School of Medicine, New York, USA.
- Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA.
- Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA. Electronic address: sripalbangalore@gmail.com.
Zitieren
APA
Zhang, R. S., Maqsood, M. H., Sharp, A. S. P., Postelnicu, R., Sethi, S. S., Greco, A., Alviar, C., & Bangalore, S. (2023). Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions, 16(21), 2644-2651. https://doi.org/10.1016/j.jcin.2023.07.042
Vancouver
Zhang RS, Maqsood MH, Sharp ASP, Postelnicu R, Sethi SS, Greco A, et al. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2644-2651. doi:10.1016/j.jcin.2023.07.042
BibTeX
@article{Zhang2023,
author = {Zhang, Robert S and Maqsood, Muhammad H and Sharp, Andrew S P and Postelnicu, Radu and Sethi, Sanjum S and Greco, Allison and Alviar, Carlos and Bangalore, Sripal},
title = {Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {21},
pages = {2644--2651},
doi = {10.1016/j.jcin.2023.07.042}
}
EUVIMED